Washington, D.C.

Join us in D.C. for a great opportunity to network with friends and colleagues during this educational symposia.

Glaukos Corporation

Glaukos Corporation is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, one of the world’s leading causes of blindness. Glaukos Corporation have pioneered Micro-Invasive Glaucoma Surgery, or MIGS, in order to revolutionize the traditional glaucoma treatment paradigm.  


Sunday, April 15, 2018

The Transformation of MIGS: Coming Soon

  • Venue: Walter E. Washington Convention Center
  • Registration and reception: 4:45 PM - 5:15 PM
  • Program: 5:15 PM - 6:15 PM
  • Supported by an educational grant from Glaukos Corporation